AU Patent

AU2012326370C9 — Lyophilized liposomes

Assigned to Jazz Pharmaceuticals Therapeutics Inc · Expires 2023-05-18 · 3y expired

What this patent protects

Lyophilized liposomal formulations with two or more encapsulated drugs are disclosed. These formulations display superior drug retention profiles and also maintain size distribution following lyophilization and reconstitution.

USPTO Abstract

Lyophilized liposomal formulations with two or more encapsulated drugs are disclosed. These formulations display superior drug retention profiles and also maintain size distribution following lyophilization and reconstitution.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012326370C9
Jurisdiction
AU
Classification
—
Expires
2023-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Jazz Pharmaceuticals Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.